Bullous erysipelas caused by community-acquired methicillin-resistant Staphylococcus aureus [5]

Dermatology

Volumn 214, Issue 2, 2007, Pages 191-192

  Del Giudice, P ^a   Blanc Amrane, V ^a  

^a Hopital Bonnet   (France)

Author keywords

Bullous erysipelas; Staphylococcus aureus, methicillin resistant

Indexed keywords

EXFOLIATIN; PANTON VALENTINE LEUKOCIDIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL FEATURE; ERYSIPELAS; HUMAN; LETTER; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; ERYSIPELAS; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33847742568     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098585     Document Type: Letter

References (11)

1. Krasagakis K, Samonis G, Maniatakis P, Georgala S, Tosca A: Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. Dermatology 2006;212:31-35.
2. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, et al: Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-598.
3. Groom AV, Wolsey DH, Naimi TS, et al: Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201-1205.
4. Purcell K, Fergie JE: Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infection in South Texas children. Pediatr Infect Dis J 2002;21:988-989.
5. Salgado CD, Farr BM, Calfee DP: Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-139.
6. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, et al: Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-2984.
7. Vandenesch F, Naimi T, Enright MC, et al: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9:978-984.
8. Del Giudice P, Blanc V, Durupt F, Bes M, Martinez JP, Counillon E, Lina G, Vandenesch F, Etienne J: Emergence of two populations of methicillin- resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br J Dermatol 2006;154:118-124.
9. Yamagushi T, Yokota Y, Terajima J, Hayashi T, Aepfelbacher M, Ohara M, Komatsuzawa H, Watanabe H, Sugai M: Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai District in Japan. J Infect Dis 2002;185:1511-1516.
10. Liassine N, Auckenthaler R, Descombes MC, et al: Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol 2004;42:825-828.
11. Vourli S, Perimeni D, Makri A, Polemis M, Voyiatzi A, Vatopoulos A: Infections à SARM acquises dans la communauté chez des enfants en Grèce. Euro Surveil 2005;10:78-79.